These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 33786948)

  • 1. Pursuing germline genome sequencing to reduce illness uncertainty may involve additional uncertainties for cancer patients: A mixed-methods study.
    Bartley N; Best M; Butow P
    J Genet Couns; 2021 Aug; 30(4):1143-1155. PubMed ID: 33786948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer.
    Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P
    BMC Cancer; 2018 Apr; 18(1):454. PubMed ID: 29685123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Patient Experience of Uncertainty While Waiting for Genome Sequencing Results.
    Bartley N; Napier CE; Butt Z; Schlub TE; Best MC; Biesecker BB; Ballinger ML; Butow P
    Front Psychol; 2021; 12():647502. PubMed ID: 33967906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fear of cancer recurrence in patients undergoing germline genome sequencing.
    Bartley N; Davies G; Butow P; Napier CE; Schlub T; Ballinger ML; Thomas DM; Juraskova I; Meiser B; Best MC
    Support Care Cancer; 2021 Dec; 29(12):7289-7297. PubMed ID: 34036439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling.
    Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P
    BMC Cancer; 2018 Apr; 18(1):389. PubMed ID: 29621994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient experience of uncertainty in cancer genomics: a systematic review.
    Bartley N; Napier C; Best M; Butow P
    Genet Med; 2020 Sep; 22(9):1450-1460. PubMed ID: 32424175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family communication about genomic sequencing: A qualitative study with cancer patients and relatives.
    Smit AK; Bartley N; Best MC; Napier CE; Butow P; Newson AJ; Tucker K; Ballinger ML; Thomas DM; Jacobs C; Meiser B; Goldstein D; Savard J; Juraskova I;
    Patient Educ Couns; 2021 May; 104(5):944-952. PubMed ID: 33129629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients.
    Bartley N; Best MC; Biesecker BB; Fisher A; Goldstein D; Meiser B; Thomas DM; Ballinger ML; Butow P
    Patient Educ Couns; 2022 Feb; 105(2):452-459. PubMed ID: 34016496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer patients' views and understanding of genome sequencing: a qualitative study.
    Bartley N; Best M; Jacobs C; Juraskova I; Newson AJ; Savard J; Meiser B; Ballinger ML; Thomas DM; Biesecker B; Butow P
    J Med Genet; 2020 Oct; 57(10):671-676. PubMed ID: 31980566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic counselors' perceptions of uncertainty in pretest counseling for genomic sequencing: A qualitative study.
    Park J; Zayhowski K; Newson AJ; Ormond KE
    J Genet Couns; 2019 Apr; 28(2):292-303. PubMed ID: 30741463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer patient knowledge about and behavioral intentions after germline genome sequencing.
    Napier CE; Davies G; Butow PN; Schlub TE; Best MC; Bartley N; Juraskova I; Meiser B; Tucker KM; Biesecker BB; Thomas DM; Ballinger ML;
    Patient Educ Couns; 2022 Mar; 105(3):707-718. PubMed ID: 34247865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological predictors of cancer patients' and their relatives' attitudes towards the return of genomic sequencing results.
    Meiser B; Butow P; Davies G; Napier CE; Schlub TE; Bartley N; Juraskova I; Ballinger ML; Thomas DM; Best MC;
    Eur J Med Genet; 2022 Jun; 65(6):104516. PubMed ID: 35487418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting.
    Best MC; Butow P; Savard J; Jacobs C; Bartley N; Davies G; Napier CE; Ballinger ML; Thomas DM; Biesecker B; Tucker KM; Juraskova I; Meiser B; Schlub T; Newson AJ
    Eur J Hum Genet; 2022 Aug; 30(8):930-937. PubMed ID: 35277654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
    Rasnic R; Brandes N; Zuk O; Linial M
    BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motivations and barriers to pursue cancer genomic testing: A systematic review.
    Smith-Uffen M; Bartley N; Davies G; Best M
    Patient Educ Couns; 2021 Jun; 104(6):1325-1334. PubMed ID: 33390305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who should access germline genome sequencing? A mixed methods study of patient views.
    Best MC; Butow P; Jacobs C; Savard J; Biesecker B; Ballinger ML; Bartley N; Davies G; Napier CE; Smit AK; Thomas DM; Newson AJ;
    Clin Genet; 2020 Feb; 97(2):329-337. PubMed ID: 31674008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
    Mandelker D; Zhang L; Kemel Y; Stadler ZK; Joseph V; Zehir A; Pradhan N; Arnold A; Walsh MF; Li Y; Balakrishnan AR; Syed A; Prasad M; Nafa K; Carlo MI; Cadoo KA; Sheehan M; Fleischut MH; Salo-Mullen E; Trottier M; Lipkin SM; Lincoln A; Mukherjee S; Ravichandran V; Cambria R; Galle J; Abida W; Arcila ME; Benayed R; Shah R; Yu K; Bajorin DF; Coleman JA; Leach SD; Lowery MA; Garcia-Aguilar J; Kantoff PW; Sawyers CL; Dickler MN; Saltz L; Motzer RJ; O'Reilly EM; Scher HI; Baselga J; Klimstra DS; Solit DB; Hyman DM; Berger MF; Ladanyi M; Robson ME; Offit K
    JAMA; 2017 Sep; 318(9):825-835. PubMed ID: 28873162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Known unknowns: building an ethics of uncertainty into genomic medicine.
    Newson AJ; Leonard SJ; Hall A; Gaff CL
    BMC Med Genomics; 2016 Sep; 9(1):57. PubMed ID: 27586379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer patients' experiences of realization of relatives' participation in hospital care: a qualitative interview study.
    Lemetti T; Partanen E; Hupli M; Haavisto E
    Scand J Caring Sci; 2021 Sep; 35(3):979-987. PubMed ID: 33107636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.